Pulmonary Hypertension in Patients with Common Variable Immunodeficiency
- 10 June 2021
- journal article
- research article
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 41 (7) , 1549-1562
Abstract
Purpose Common variable immunodeficiency (CVID) is known to cause infectious, inflammatory, and autoimmune manifestations. Pulmonary hypertension (PH) is an unusual complication of CVID with largely unknown characteristics and mechanisms. Methods We report the clinical, functional, hemodynamics, radiologic and histologic characteristics, and outcomes of CVID-associated PH patients from the French PH Network. Results Ten patients were identified. The median (range) age at CVID diagnosis was 36.5 (4–49) years and the median delay between CVID and PH diagnosis was 12 (0–30) years. CVID-associated PH affected predominantly women (female-to-male ratio 9:1). Most patients were New York Heart Association functional class III with a severe hemodynamic profile and frequent portal hypertension (n = 6). Pulmonary function tests were almost normal in 70% of patients and showed a mild restrictive syndrome in 30% of patients while the diffusing capacity for carbon monoxide was decreased in all but one patient. High-resolution computed tomography found enlarged mediastinal nodes, mild interstitial infiltration with reticulations and nodules. Two patients had a CIVD-interstitial lung disease, and one presented with bronchiectasis. Pathologic assessment of lymph nodes performed in 5 patients revealed the presence of granulomas (n = 5) and follicular lymphoid hyperplasia (n = 3). At last follow-up (median 24.5 months), 9 patients were alive, and one patient died of Hodgkin disease. Conclusion PH is a possible complication of CVID whose pathophysiological mechanisms, while still unclear, would be due to the inflammatory nature of CVID. CVID-associated PH presents as precapillary PH with multiple possible causes, acting in concert in some patients: a portal hypertension, a pulmonary vascular remodeling, sometimes a pulmonary parenchymal involvement and occasionally an extrinsic compression by mediastinal lymphadenopathies, which would be consistent with its classification in group 5 of the current PH classification.Keywords
This publication has 32 references indexed in Scilit:
- Morbidity and mortality in common variable immune deficiency over 4 decadesBlood, 2012
- Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertensionRespiratory Research, 2010
- Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromesBlood, 2009
- Nodular regenerative hyperplasia: The main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalitiesJournal of Hepatology, 2008
- Pulmonary hypertension in Hodgkin's diseaseThorax, 2007
- Use of intravenous immunoglobulin in human disease: A review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and ImmunologyJournal of Allergy and Clinical Immunology, 2006
- Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosisThorax, 2005
- Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiencyJournal of Allergy and Clinical Immunology, 2004
- Echocardiographic abnormalities in primary antibody deficiencyPostgraduate Medical Journal, 2004
- Common Variable Immunodeficiency: Clinical and Immunological Features of 248 PatientsClinical Immunology, 1999